TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

8d ago

TGTX

PremiumPress Releases

TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis

8d ago

TGTX

PremiumPress Releases

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

11d ago

TGTX

PremiumPress Releases

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

2M ago

TGTX

PremiumPress Releases

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

2M ago

TGTX

PremiumPress Releases

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results

2M ago

TGTX

PremiumPress Releases

TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)

2M ago

TGTX

More TGTX News >

TGTX News on the Web

2024-04-18

TG Therapeutics contact with VA 'unequivocal win,' says JPMorgan

The Fly

Neutral

2024-03-25

Should You Invest in the SPDR S&P Biotech ETF (XBI)?

Zacks

Neutral

2024-03-19

Is TG Therapeutics, Inc.'s Recent Price Movement Underpinned By Its Weak Fundamentals?

Yahoo Finance

Neutral

2024-03-15

Tg therapeutics director sells shares worth over $79k

Investing.com

Neutral

2024-03-15

Tg therapeutics director sells shares worth over $79k

Investing.com

Neutral

2024-03-13

Director Laurence Charney Sells 22,000 Shares of TG Therapeutics Inc (TGTX)

GuruFocus News

Neutral

2024-03-13

13 Best Biotech Stocks To Buy Under $20

Yahoo Finance

Neutral

2024-03-08

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

TGTX

Sector Average

Media Buzz

This Week1 articles

Weekly Average1 articles

News Sentiment

This Week50%

Sector Average62%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TGTX’s Media Buzz Sentiment?

1 articles about TGTX were published this week. In an average week, 1 articles are published.

What is TGTX’s weekly average amount of articles?

In an average week, 1 articles about TGTX are published.

What is TGTX’s News Sentiment?

50% of articles about TGTX were positive this week, compared to its sector average of 62%.

Healthcare Stocks that are Trending in the News

ELVElevance Health

INSPInspire Medical Systems

CGEMCullinan Management

EWEdwards Lifesciences

MRNSMarinus

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing